decreased sensitivity to induced morbidity/mortality_Tgm2<tm1Gml>/Tgm2<tm1Gml>

http://metadb.riken.jp/0009764IC57BL6Tgm2tm1GmlTgm2tm1GmlTgm2tm1Gml

decreased sensitivity to induced morbidity/mortality_Tgm2<tm1Gml>/Tgm2<tm1Gml>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transglutaminase 2, C polypeptide
  http://metadb.riken.jp/db/mgi_rdf/MGI:98731

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tgm2<tm1Gml>/Tgm2<tm1Gml>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tgm2<tm1Gml>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased sensitivity to induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009764

文献

http://purl.org/net/cito/citesAsAuthority

• Laura. Falasca, et.al., Transglutaminase type II is involved in the pathogenesis of endotoxic shock., Journal of immunology (Baltimore, Md. : 1950), 2008, 180
  http://rdf.ncbi.nlm.nih.gov/pubmed/18250473